Imadrax

Amoxicillin, the active ingredient in Imadrax, is a penicillin beta‑lactam antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections in adults and children, including respiratory, ear, urinary and skin infections. GNH USA supplies Imadrax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Amoxicillin is a broad‑spectrum penicillin that targets bacterial cell‑wall synthesis, making it useful for several common infection categories. - Respiratory tract infections: effective for community‑acquired pneumonia, bronchitis and sinusitis. - Otitis media: treats middle‑ear bacterial infections in children and adults. - Urinary tract infections: clears uncomplicated cystitis caused by susceptible organisms. - Skin and soft tissue infections: resolves cellulitis and wound infections caused by susceptible bacteria.

Adverse reactions to amoxicillin can vary from mild to severe, and patients should be aware of both common and rare events.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: loose stools that may be self‑limiting. - Rash: non‑specific skin eruption, often mild. - Vomiting: occasional emesis, especially with higher doses. - Headache: transient, usually resolves without intervention. - Taste disturbance: altered taste perception during therapy.

Serious or Rare Side Effects: - Anaphylaxis: life‑threatening allergic reaction requiring immediate medical care. - Stevens‑Johnson syndrome: severe mucocutaneous blistering. - Clostridioides difficile colitis: antibiotic‑associated severe diarrhea. - Serum sickness‑like reaction: fever, arthralgia, and rash. - Hepatotoxicity: elevated liver enzymes or jaundice. - Hematologic abnormalities: neutropenia, thrombocytopenia, or hemolytic anemia.

Before prescribing amoxicillin, clinicians should evaluate patient history and monitor for specific risks. - Allergy assessment: confirm no known hypersensitivity to penicillins or cephalosporins. - Renal function: adjust dose in patients with impaired clearance. - Hepatic function: monitor liver enzymes in patients with pre‑existing liver disease. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Concomitant antibiotics: avoid unnecessary combination therapy that may increase resistance. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Amoxicillin may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Probenecid: reduces renal excretion, raising amoxicillin plasma levels. - Oral contraceptives: may diminish hormonal effectiveness, increasing pregnancy risk. - Methotrexate: can increase methotrexate toxicity by reducing clearance.

Moderate Interactions (Monitor Closely): - Warfarin: potentiates anticoagulant effect, requiring INR monitoring. - Allopurinol: heightened risk of skin rash, including severe reactions. - Ciprofloxacin: may antagonize the bactericidal activity of amoxicillin.